Our Company
Harrow, a growing leader in the North American ophthalmic pharmaceutical market, is dedicated to delivering innovative, accessible, and affordable eyecare solutions. For over a decade, we have partnered with U.S. eyecare professionals to develop a diverse portfolio of high-quality products used in ophthalmic surgeries, medications prescribed to treat chronic and acute care conditions such as dry eye disease, glaucoma, allergies, infections, and other ophthalmic inflammatory disorders, as well as products used by retinal specialists for in-office procedures, such as intravitreal injections. By prioritizing clinical value – to the provider and the patient – Harrow empowers professionals to enhance patient outcomes and preserve vision. By combining our culture of creativity, entrepreneurship and groundbreaking innovation with operational discipline and strong financial performance, we are building a future where life-changing ophthalmic treatments are within reach for all.